Melone V, Salvati A, Palumbo D, Giurato G, Nassa G, Rizzo F, Palo L, Giordano A, Incoronato M, Vitale M, et al
As the global economy grows, obesity has emerged as a significant public health challenge
The FDA has approved Wegovy (semaglutide 2.4 mg), Zepbound (tirzepatide), and Saxenda (liraglutide 3 mg) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
One of the most talked-about effects is known as "Ozempic Face," (Donnelly, 2024) which occurs when rapid weight loss leads to a loss of facial volume and sagging skin
Many women notice that even if the scale doesnt change dramatically, their waistline increases, muscle mass decreases, and their body composition feels different